Its typically mild and improves significantly as your body adjusts
10.1038/sj.mp.4000805 28
GLP-1 receptor agonists used in obesity care aim to reduce hunger and improve satiety signalling for many patients, alongside diet and physical activity, when a UK-registered prescriber selects them
These medications can be incredibly helpful, but theyre not risk-free, especially during pregnancy. The study found that 2.2% of women became pregnant within six months of starting GLP-1 treatment with pregnancy rates highest among younger women with diabetes, and among women without diabetes in their early thirties
Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, et al
Association between osteoarthritis and cardiovascular disease: systematic review and meta-analysis